Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunology in Pittsburgh.

Olivera J Finn1, Russell D Salter

  • 1E1040 Biomedical Science Tower, University of of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA. ojfinn@pitt.edu

Immunologic Research
|March 6, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immune cell transcriptional profiles from pre-vaccination peripheral blood predict immune response to preventative MUC1 cancer vaccine.

European journal of cancer (Oxford, England : 1990)·2025
Same author

Prospective Examination of Cellular and Soluble Mediators of Immune Dysregulation and Their Association with Lung Cancer Risk.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2025
Same author

A Multicenter Pilot Study of MUC1 Vaccine in Current and Former Smokers at High Risk for Lung Cancer.

medRxiv : the preprint server for health sciences·2025
Same author

Preventative Cancer Vaccine-Elicited Human Anti-MUC1 Antibodies Have Multiple Effector Functions.

Antibodies (Basel, Switzerland)·2024
Same author

Pre-vaccination transcriptomic profiles of immune responders to the MUC1 peptide vaccine for colon cancer prevention.

Frontiers in immunology·2024
Same author

Tumor-Associated Antigen Burden Correlates with Immune Checkpoint Blockade Benefit in Tumors with Low Levels of T-cell Exhaustion.

Cancer immunology research·2024
Same journal

Emapalumab plus conventional therapy with or without ruxolitinib for pediatric hemophagocytic lymphohistiocytosis: a single center retrospective study.

Immunologic research·2026
Same journal

Immunological spectrum in patients with thymoma: beyond good syndrome.

Immunologic research·2026
Same journal

Microbiome immune crosstalk in Sjögren's syndrome: mechanistic insights and translational perspectives.

Immunologic research·2026
Same journal

Immune checkpoint inhibitor-induced myasthenia gravis and myocarditis: a fatal immune-related adverse event.

Immunologic research·2026
Same journal

TRIM28 and TRIM32: multifaceted regulators of innate immunity and antiviral defence.

Immunologic research·2026
Same journal

Decoding PANoptosis: Crosstalk of cell death pathways in immunity and inflammation.

Immunologic research·2026
See all related articles

The University of Pittsburgh School of Medicine boasts a rich history in immunology, from polio vaccine development to pioneering cancer immunology research. Its legacy continues with advanced training and significant contributions to transplantation and immunotherapy.

Area of Science:

  • Immunology
  • Transplantation Immunology
  • Cancer Immunology and Immunotherapy

Background:

  • The University of Pittsburgh School of Medicine has a distinguished history in immunology research and training.
  • The institution's legacy includes contributions from pioneers like Dr. Jonas Salk (polio vaccine) and Dr. Niels Jerne (Jerne Plaque Assay).

Observation:

  • The establishment of the Biomedical Science Tower commemorates Dr. Thomas Starzl's work in solid-organ transplantation.
  • Research in graft rejection and tolerance induction has trained numerous specialists.
  • The founding of the University of Pittsburgh Cancer Institute (UPCI) spurred new initiatives in cancer immunology.

Findings:

  • The University of Pittsburgh has a long-standing tradition of excellence in immunology.

Related Experiment Videos

  • Significant advancements have been made in transplantation immunology and cancer immunotherapy.
  • The institution has successfully recruited leading researchers in tumor immunology.

    • Implications:

    • The University of Pittsburgh continues to be a leading center for immunology research and education.
    • The historical foundation supports ongoing innovation in transplantation and cancer immunotherapy.
    • The recruitment of top talent ensures continued progress in understanding and treating immune-related diseases.